InvestorBrandNetwork (IBN) Content Platform

Lottery.com (NASDAQ: LTRY), the world’s leading provider of lottery results data servicing global publishers, search engines, and voice assistants, has a new appointed a new independent member of its board of directors. The company announced that Nick Kounoupias, a veteran experienced attorney with more than four decades of experience, has accepted the appointment, which is part of the company’s restructuring and initiative to improve its disclosure and reporting controls and return to compliance with NASDAQ’s continued listing requirements. Kounoupias has garnered vast experience with digital, media and technology companies with a special expertise on corporate, governance and intellectual property (“IP”) across multiple sectors. The founder and CEO of Kounoupias IP, a boutique IP consultancy with offices in England and Cyprus, Kounoupias can provide strategic guidance on digital technology and IP matters and is widely recognized as a top expert in antipiracy and anticounterfeiting; he also possesses extensive experience of managing and conducting investigations in IP and other sectors. “We are delighted Nick has agreed to join the board, substantially bolstering the depth of our corporate governance expertise,” said Lottery.com chair Matthew McGahan in the press release. “His appointment is particularly timely as Lottery.com is keenly focused on regaining compliance with the NASDAQ Listing Rules following the hiatus we inherited as a new board. In this regard, the new management team is working with our auditors and other advisers to substantially improve our disclosure and reporting controls, and other areas. Nick’s legal oversight and experience is expected to help our intentions these are implemented smoothly, and we very much look forward to working with him.”

In addition, Lottery.com announced that it has received a notice from NASDAQ Stock Market Exchange, that it does not comply with filing requirements; the company has not yet filed its annual report for the year ended Dec. 31, 2022. As a result, Lottery.com management has requested a panel hearing to appeal the exchange’s delisting determination.

To view the full press release, visit https://ibn.fm/MRC6K

About Lottery.com Inc.

Lottery.com, Inc. plans to regain its position as a leading technology company whose goal is to transform how, where and when lotteries are played. It plans to re-engage mobile and online platforms to enable players and commercial partners located throughout the United States and other countries to remotely purchase safe and legally sanctioned lottery games. The Company is being restructured for growth opportunities in entertainment and sports, including potential acquisitions of companies and or technologies and related opportunities, funding permitting. In all that it has done or does, Lottery.com’s mission remains the same: an uncompromising passion to innovate, grow a new demographic of enthusiasts, deliver responsible and trusted solutions, and promote community and philanthropic initiatives. To learn more about the company, visit www.Lottery.com.

NOTE TO INVESTORS: The latest news and updates relating to Lottery are available in the company’s newsroom at https://ibn.fm/Lottery

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tingo Group Inc. (NASDAQ: TIO), a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East, announced that it has received a notification letter from NASDAQ that its stock has been under a minimum bid price of $1 for a period of 30 days. As a result, the company has 180 calendar days to achieve a closing bid price of at least $1 per share for a minimum of 10 consecutive trading days to regain compliance with the NASDAQ exchange. The announcement noted that an additional 180-day period may be granted to regain compliance if certain guidelines are met. “Following the announcement on March 31, 2023, of our financial results for the year ended Dec. 31, 2022, and the filing of our Form 10-K and Auditor Report from Deloitte, which evidenced we became significantly profitable from the date of the completion of our acquisition of Tingo Mobile Limited on November 30, 2022, we confidently believe NASDAQ compliance will be regained imminently,” said MICT CEO Darren Mercer in the press release. “As the position stands today, our bid price has closed at higher than $1 for the past eight consecutive trading days. With the company’s Pro Forma Consolidated Revenues for 2022 amounting to $1.152 billion and its Pro Forma Consolidated Operating Income for 2022 amounting to more than $550 million, the previously mentioned substantial disconnect between our stock price and financial performance remains clear.”

To view the full press release, visit https://ibn.fm/7g7yL

About Tingo Group Inc.

Tingo Group is a global fintech and agri-fintech group of companies with operations in Africa, southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is the leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device as a service” smartphone and preloaded platform product. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing the farmers with access to services including, among others, the Nwassa seed-to-sale marketplace platform, insurance, microfinance, and mobile phone and data top-up. Tingo Group’s other Tingo business verticals include TingoPay, a SuperApp in partnership with Visa that offers a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food-processing business that processes raw foods into finished products such as rice, pasta and noodles; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China, with 130-plus offices located in China’s cities and major town, and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore. For more information, visit the company’s website at www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/TMNA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, has filed a shelf prospectus supplement. The prospectus is in connection with MYCOF’s previously announced Common Share Subscription Agreement with a third-party investor. The filing is an addition to the company’s Final Short Form Base Shelf Prospectus for the province of Québec and Amended and Restated Final Short Form Base Shelf Prospectus for each of the provinces of Canada; those filings were dated Jan. 28, 2022. According to the company, the prospectus supplement is the first supplement filed in connection with the subscription agreement and provides, among other things, that the company is qualifying the distribution of some 10,309,278 common shares of the company to the investor; the shares are provided at $0.485 per share resulting in gross proceeds of up to $5 million. The company also noted that the first tranche of the first issuance under the subscription agreement has closed, which was comprised of 1,340,206 shares.

To view the full press release, visit https://ibn.fm/lSE7G

About Mydecine Innovations Group Inc.

Mydecine Innovations is a biotechnology company developing the next generation of innovative medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (“PTSD”). The core strategy blends advanced technology with an elaborate infrastructure for drug discovery and development. Mydecine’s dedicated multinational team constantly develops new paths for breakthrough treatment solutions in areas with considerable unmet needs. By collaborating with some of the world’s leading specialists, the company aspires to responsibly speed up the development of breakthrough medications to provide patients with safer and more-effective treatment solutions. At the same time, Mydecine’s approach focuses on the next generation of psychedelic medicine by creating innovative compounds with unmatched therapeutic potential through its clinical trial efforts with world-class scientific and regulatory expertise. Based out of Colorado, Mydecine was founded in 2020, and has offices in Canada and the Netherlands.

NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

FE Battery Metals (CSE: FE) (OTCQB: FEMFD), a publicly traded Canadian mineral exploration company, is reporting on the recent drill hole LC23-50 from its current 2023 drill program at the Quebec-based Augustus Lithium Property. According to the announcement, drill hole intersected multiple sections of lithium mineralization, including a 17.45-meter-wide section of 1.19% lithium oxide (Li2O) at 82.4-meter drilled depth. The drill hole also intersected eight lithium pegmatite intercepts, with all pegmatites having anomalous values of other rare metals. Based on the results, the company noted that it is planning both follow-up drilling and 3D modelling of the lithium-bearing rock units. “We are very excited to see such promising drill results at Augustus and are currently endeavoring to define the size and shape of the high-grade zones,” said FE Battery Metals CEO and director Gurminder Sangha in the press release. “With Quebec now a hard rock lithium hot spot, this is a significant milestone for our company. We look forward to further unlocking the potential of Augustus, which is located just a few kilometres from the now-operational North American Lithium Mine.”

To view the full press release, visit https://ibn.fm/7ddUL

About FE Battery Metals Corp.

FE Battery Metals is a Canadian mineral exploration company with a primary focus of acquiring mineral properties in the battery metal sector. The company’s goal is to identify, acquire and explore North American mineral prospects with a primary focus on lithium. The company’s strategy is to acquire and advance projects through prospecting and early-stage exploration; source joint venture partners to finance future exploration and project development; and create shareholder value through exploration success. For more information about the company, please visit www.FirstEnergyMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to FEMFF are available in the company’s newsroom at https://ibn.fm/FEMFF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Save Foods (NASDAQ: SVFD) (FSE: 80W), an agri-food tech company specializing in eco-crop protection that helps to reduce food waste and ensure food safety while reducing the use of pesticides, today announced that it has acquired direct ownership of common shares in the capital of Plantify Foods (TSX.V: PTFY) in the amount of 30,004,349 common shares. Plantify’s head office is located at 2264 East 11th Avenue, Vancouver, British Columbia, V5N 1Z6, and its common shares trade on the TSX Venture Exchange under the symbol PTFY. The acquisition was completed pursuant to a securities exchange agreement between the companies, dated March 31, 2023, at a purchase price of CAD$0.05 per common share acquired in exchange for 1,164,374 shares of common stock of Save Foods. Immediately prior to the acquisition, Save Foods did not own or exercise control or direction over any securities of Plantify. As a result of the acquisition, Save Foods exercises control or direction over 19.99% of the total number of Plantify’s issued and outstanding common shares.

To view the full press release, visit https://ibn.fm/90L9t

About Save Foods Inc.

Save Foods is an innovative, dynamic company addressing two of the most significant challenges in the agri-food tech industry: food waste and loss and food safety. The company is dedicated to delivering integrated solutions for improved safety, freshness and quality, every step of the way from field to fork. Collaborating closely with its customers, Save Foods develops new solutions that benefit the entire supply chain and improve the safety and quality of life of both workers and consumers alike. Its initial applications are in post-harvest treatments in fruit and vegetable packing houses processing produce including citrus, avocado, pears, apples and mangos. By controlling and preventing pathogen contamination and significantly reducing the use of hazardous chemicals and their residues, Save Foods’ treatments not only prolong fresh produce shelf life and reduce food loss and waste, but they also ensure a safe, natural and healthy product. For more information, visit the company’s website at www.SaveFoods.co.

NOTE TO INVESTORS: The latest news and updates relating to SVFD are available in the company’s newsroom at https://ibn.fm/SVFD         

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Massachusetts-headquartered cybersecurity services and technology provider SideChannel Inc. has dedicated itself to serving SMB companies who may be unable to employ on-staff cyber risk management personnel, delivering expertise on contract instead
• SideChannel recently bolstered its “virtual” chief information security officer (“vCISO”) service by partnering with automated supply chain risk management platform developer Darkbeam, a London-based company similarly focused on client cyber security
• Darkbeam’s platform provides tools for clients to do data dives on affiliated domains and monitor changes in their security status by analyzing a “Cyber Intelligence Quotient”
• SideChannel also offers clients a microsegmentation tool as a software-as-a-service (“SaaS”) subscription product, which the company also can operate as a managed service if clients prefer

Businesses have enough challenges managing their potential vulnerability to cyber attacks dwithout having to worry about the cyber risk of other companies involved in their supply chain as well.

Cybersecurity services and technology provider SideChannel (OTCQB: SDCH) announced recently that it is partnering its virtual chief information security officer (“vCISO”) expertise with London-based cyber intelligence provider Darkbeam’s advanced risk management platform to grant clients greater tools for…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares. According to the announcement, the current ADS ratio is one ADS to five ordinary shares; that ratio will change to one ADS to thirty ordinary shares. According to the announcement, the company anticipates the ADS ratio change will be effective on or about April 21, 2023, with the effect of the change on ADS trading prices on the NASDAQ market expected to occur at the open of trading on April 21, 2023, ET. FRSX noted that there will be no change to its ordinary shares. “Effective April 21, 2023, ADS holders of record in certified form will be required on a mandatory basis to surrender their ADSs to the depositary bank for the company’s ADS program, The Bank of New York Mellon, for cancellation and will receive one new ADS in exchange for every six existing ADSs then held in connection with the ADS Ratio Change, with further details to be provided in the notice by the Depositary Bank,” the company states in the press release. “Holders of uncertificated ADSs in the Direct Registration System  and in the Depository Trust Company will have their ADSs automatically exchanged and need not take any action.”

To view the full press release, visit https://ibn.fm/u8JMR

About Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings is a technology company developing smart multispectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries — Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd. — Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time, pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information, visit the company’s website at www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

AnPac Bio-Medical Science (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, has announced the closing of its previously announced registered direct offering. The offering, a securities purchase agreement with institutional investors, was for $3 million of its American Depositary Shares (“ADSs”), prefunded warrants to purchase ADSs and warrants to purchase ADSs. According to the announcement, the company anticipates using the net proceeds from the offering for its R&D development activities as well as for working capital and general corporate purposes.

To view the full press release, visit https://ibn.fm/tQyZt

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2023. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. The company intends to enter the business-to-business e-commerce food business with the formation of its wholly owned subsidiary Fresh2 Technology and the acquisition of Fresh2 Ecommerce Inc. For more information about the company, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• D-Wave has worked on quantum hybrid applications with commercial customers including industry leaders like Volkswagen, Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, Accenture, BBVA, NEC Corporation, Pattison Food Group Ltd., DENSO, and Lockheed Martin
• The company’s intellectual property portfolio includes more than 210 issued US patents and more than 100 peer-reviewed papers in leading scientific journals
• D-Wave’s customer success stories showcase the company’s quantum computing technology in action

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, focused on delivering value to customers via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection, and financial modeling, showcases the tangible value of its practical quantum computing solutions through its customer success stories.

D-Wave has worked with commercial customers include blue-chip industry leaders like Volkswagen, Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, Accenture, BBVA, NEC Corporation, Pattison Food Group Ltd., DENSO, and Lockheed Martin, in addition to…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward-Looking Statements

This article contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which statements are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Forward-looking statements in this article include, but are not limited to, statements regarding the release and performance of the Advantage2 processor. We cannot assure you that the forward-looking statements in this article will prove to be accurate. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks; customer acceptance of our products and services; and the uncertainties and factors set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the registration statement on Form S-1 filed by the Company with the SEC on February 13, 2023, as well as factors associated with companies, such as D-Wave, that are engaged in the business of quantum computing, including anticipated trends, growth rates, and challenges in those businesses and in the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and or timing thereof; the performance of our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; the risk that our securities will not maintain the listing on the NYSE; changes in applicable laws and regulations; the effect of pandemics, geopolitical events, natural disasters, wars, or terrorist acts on our business or the economy in general; and the impact of inflation. Furthermore, if the forward-looking statements contained in this article prove to be inaccurate, the inaccuracy may be material. In addition, you are cautioned that past performance may not be indicative of future results. In light of the significant uncertainties in these forward-looking statements, you should not place undue reliance on these statements in making an investment decision or regard these statements as a representation or warranty by any person we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this article represent our views as of the date of this article. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this article.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

IBN, a multifaceted communications organization engaged in connecting companies to the investment community, today announced release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. Elnaz Sarraf, founder and CEO of ROYBI, the creator of children’s intelligent educational robots and digital content, joined the program to discuss the founding and vision of ROYBI. “Before ROYBI, I spent 5-6 years with my first company, iBaby, which had baby monitors. I spent a lot of time with parents, getting to know their needs and pain points. Education has always been something that would come up. They were even asking about educational lullabies for babies. From that point, I developed a huge passion for technology and education. So, I decided to start my new journey by founding a technology company that implements educational content,” Sarraf said. “Long story short, we did a lot of research in the market beginning in 2017. Finally, we came up with the idea for ROYBI Robot, an educational robot for kids ages 3-7. We focus on language learning, vocabulary acquisition and communication skills. We started the company in 2019, and we are now available in major retail stores. We also have some pilot programs with schools. I would say ROYBI really started as a passion, and we are also really focused on the impact of our work on children’s lives.”

To view the full press release, visit https://ibn.fm/Eup4j

About ROYBI

ROYBI’s mission is to create the ultimate virtual platform providing one-to-many educational impact for students of all ages. The company’s products and services include its educational robot and digital content for children. At the same time, RoybiVerse will offer the digital experience through various content for all age groups, K-12 to college-level skills. The company expects to grow quickly as it finalizes world-class partnerships. The partnerships will bring users a wealth of knowledge, content and experience unlike any other platform. Whether learning on robots or the metaverse, ROYBI aims to ensure that learning continues anywhere at any time. For more information, visit the company’s website at www.ROYBIRobot.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, received three new purchase orders for its K1 emergency communication systems. The company also deployed another K5 ASR at a healthcare facility. This growth is symbolic of the company’s growing momentum and increasing sales in an array of sectors. The K1 orders came from VIA Metro Transit of San Antonio, Texas; authorized partner Embry-Riddle Aeronautical University in Florida; and a New-Mexico-based public tribal land-grant community college.

The company noted that the ASR was sent to an existing Ohio-based healthcare client — a pharmaceutical’s global manufacturer and distributor of medical and laboratory products, and provider of performance and data solutions for healthcare. The add-on K5 ASR will be surveilling a second location to provide perimeter protection in the parking lot around its facility.

In addition, the Knightscope’s robot roadshow will be moving from Broadway to the boardwalk. After concluding its debut at Times Square, the tour heads to New Jersey’s famous boardwalk, where its space-age, climate-controlled “Pod” will be set up at the Resorts Casino Hotel from April 18–20, 2023. Public viewing for the Robot Roadshow will be 10 a.m. – 2 p.m. ET.

Knightscope CEO and chair William Santana Li is also wrapping up the last few days of the company’s 10 Town Halls, scheduled as part of KSCP’s 10th anniversary. During the online events, Li will answer questions from supporters, investors and analysts in an intimate online forum with no moderator. The town halls are scheduled over several different time periods and dates to accommodate busy schedules of those who are interested in attending.

To sign up for a town hall, visit https://ibn.fm/hlBjf

To sign up for a roadshow slot, visit https://ibn.fm/XHflA

To view the full press release, visit https://ibn.fm/MLW5C

About Knightscope, Inc.

Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots that deter, detect and report. The company’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based products and services to the life sciences industry, has renewed its partnership with NutraLife Biosciences (OTC: NLBS), a highly respected manufacturer and distributor of nutraceuticals primarily sold on a direct-to-consumer basis. The two companies first began working together four years ago, and this new collaboration is focused on combining PBIO’s best-in-class UltraShear nanoemulsification platform with NLBS’s highly effective nutraceuticals product formulation, marketing, sales and distribution capabilities. The focus of the partnership will be to develop, market and sell a higher-performing line of next-generation nutraceuticals. “Our UltraShear nanoemulsions platform has left initial collaborators across diverse markets awestruck over the potency and economic efficiencies that we can deliver to their customers and to their bottom line,” said Pressure Biosciences president and CEO Richard T. Schumacher in the press release. “Our priority has been to select partners who have the existing networks and infrastructure to ‘hit the ground running’ with the uniquely differentiated, superior product opportunities that we offer and enable for them. [The] team at NLBS are precisely what we seek — ready to leverage their extensive existing customer base and market channels to achieve early and rapidly scaling sales traction for innovative and re-engineered products across the nutraceuticals product frontier. In particular, they have been seeking a truly effective nano-CBD tincture solution — and we have that that product already developed and well proven in the hands of independent external experts.”

To view the full press release, visit https://ibn.fm/uGkdQ

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control biomolecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of PBIO’s pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the biopharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

BREATHE! Convention has announced its pursuit of the Edenark Group ISO 14001 environmental sustainability certification program as part of a dedicated effort for more sustainable and environmentally responsible Web3 practices.

The Edenark Group ISO 14001 is the world’s premier environmental sustainability certification program, designed for small to mid-sized enterprises to attain the world’s most popular environmental certification standard in a program that is specifically designed and priced for them. This certification program helps organizations progressively improve at a pace that works for their needs, defining how they interact internally, externally, and with the environment.

To view the full press release, visit https://ibn.fm/P8NQi

About BREATHE!

Taking place on May 3-5, 2023 at the Las Vegas Convention Center, BREATHE! Convention is connecting the Web3 universe that brings the power and utility of Web3 technology straight into the palm of your hands.

With thousands of professional attendees anticipated and a Keynote agenda designed to educate techies and newbies alike, BREATHE! serves as the genesis of Web3 adoption across the ever-expanding universe of Web3 technology, including Blockchain, Crypto, DeFi, Metaverse and NFT application.

BREATHE! is built on Web3 Rails, making it the first ever convention to not only educate people about this emerging technology, but also showcases real-world applications and experiences that can improve our daily lives in ways the global economy previously never thought possible.

Organized and developed by a passionate team of Web3 enthusiasts and investors, BREATHE! serves as the launch point for the Web3 revolution, where world-changing tools and concepts like AI and digital ownership bring a massive leap forward into the future of business.

Visit www.breatheconvention.com to secure your ticket to attend and inquire for exhibiting and sponsoring opportunities. BREATHE! is active on Twitter and Discord, providing the latest news and updates to the event.

Produced by 5AM Global
Press Contact: Brian Edmiston
833-931-3128 
Ext. 710
[email protected]

5AM Global
8275 S. Eastern Ave, Suite 200
Las Vegas, NV 89123
USA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Reklaim (TSX.V: MYID) (OTCQB: MYIDF), the destination for consumers to access and reclaim their data, today announced the filing of 2022 annual audited financial results for the year ending Dec. 31, 2022. Among the highlights, the company reported year-over-year revenue growth of 136% to $2,361,110 from $1,000,200. “2023 marks the beginning of the enforcement period for state-level privacy regulation in California and Virginia, with three additional states to be added in 2023. The ability of marketers to use unconsented data will continue to deteriorate rapidly, which will create an ever-increasing opportunity for Reklaim to add more clients looking to replace their historical non-compliant data provider,” said Reklaim CEO Neil Sweeney. “In the past year, we have driven massive revenue and gross margin increases while streamlining costs to drive Reklaim towards profitability. Growth and profitability are our focus for 2023. As outlined in our MD&A, the privacy world is accelerating to include the consumer, and no company is better positioned to take advantage of this trend. We expect to maintain this same trajectory in 2023.”

To view the full press release, visit https://ibn.fm/5Ifp1

About Reklaim Ltd.

Consumer data and the evolution of privacy drive Reklaim. Offering compliant, zero-party data to Fortune 500 brands, platforms and data companies, Reklaim allows consumers to visit the application, confirm their identity, and unveil data collected and sold for years without the consumer’s explicit consent. Reklaim enables consumers to take back control of this data by setting up a Reklaim account through which, should they choose to, they can be compensated for their data. To view more information about Reklaim, visit https://investors.reklaimyours.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

NextPlat Corp. (NASDAQ: NXPL), a global e-commerce provider, announced the execution of a binding securities purchase agreement. The agreement was made April 5, 2023, with a strategic, accredited investor. According to the announcement, NXPL agreed to sell 3,428,571 shares of the company’s common stock at $0.0001 par value per share. The offering price of the stock was $1.75 per share, or the closing price of the stock on April 4, 2023. The company noted that, in connection with the agreement, the Investor subscribed for, and NextPlat will receive, gross proceeds of approximately $6 million for the stock. The agreement is expected to close on or before April 10, 2023. “This transaction will enhance the company’s balance sheet providing additional cash for working capital including supporting the company’s newly launched e-Commerce development program, which is designed to assist Florida-based businesses to access international markets in Asia,” the announcement stated.

To view the full press release, visit https://ibn.fm/oYa09

About NextPlat Corp

NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets for physical and digital assets. The company intends to collaborate with businesses, optimizing the ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications services division through its Global Telesat Communications Ltd. and Orbital Satcom Corp. business units, which offer voice, data, tracking and IoT services to customers worldwide through multiple global storefronts. For more information about the company, please visit www.NextPlat.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

LQwD Fintech (TSX.V: LQWD) (OTC: LQWDF), a company focused on building infrastructure on the Bitcoin Lightning Network global micropayment system, has appointed an independent director. Alex P. Guidi, an experienced public company executive, investor, and successful venture capitalist, will be serving on the company’s board of directors alongside Shone Anstey, Ashley Garnot, Pino Perone and Kim Evans. As principal shareholder and founder of the IREMCO Group, a cluster of highly successful, senior board-listed companies, Guidi brings a depth of experience and expertise to his new role. In conjunction with Guidi’s board appointment, LQwD also announced a nonbrokered private placement of 468,750 units of the company at a price of $0.64 per unit resulting in gross proceeds of $300,000. According to the announcement, each unit includes one common share of the company and one common share purchase warrant. The private placement will be fully subscribed by Guidi. LQwD anticipates using the proceeds from the private placement to expand its Lightning Network business and for general working capital purposes. Completion of the placement is subject to the receipt of all necessary regulatory approvals, including acceptance of the TSX Venture Exchange.

To view the full press release, visit https://ibn.fm/gJ93v

About LQwD Fintech Corp.

LQwD is a Lightning Network service provider (“LSP”) focused on developing payment infrastructure and solutions accelerating the global megatrend of Bitcoin adoption through the Lightning Network. The company’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling Bitcoin. LQwD also holds Bitcoin that is used as an operating asset establishing nodes and payment channels on the Lightning Network. For more information, please visit www.LQwDFintech.com.

NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Exro Technologies (TSX: EXRO) (OTCQB: EXROF), a leading clean-technology company that has developed new-generation power control electronics which expand the capabilities of electric motors and batteries, has appointed Rod Copes, a current director, as interim chair. The move comes as executive chairman Mark Godsy announced he would be leaving the position, effective March 31, 2023. According to the announcement, the transition aligns with Exro’s evolution into series production in Q3 of this year and positioning for a listing on the NASDAQ exchange. “We are also very pleased to announce the appointment of Rod Copes as interim chairman of the Board,” said Exro Technologies CEO Sue Ozdemir in the press release. “Rod’s decades of unique experience in scaling manufacturing operations at both Rivian and Harley-Davidson in the U.S., as well as listing on the NASDAQ exchange, serve as tremendous assets to Exro. On behalf of everyone at Exro and the board, we welcome Rod to his new position and look forward to working with him to continue our efforts to build significant value for our shareholders. . . . “Exro has been very fortunate to have Mark as part of our leadership team. Mark’s entrepreneurial insights have helped to guide the business and establish a framework that sees a thoughtful leadership transition at the right time in the company’s development. On behalf of the board and all our employees, we want to thank him for his years of dedicated service to the board of directors and the company and wish him well in his other endeavours.”

To view the full press release, visit https://ibn.fm/HwOkI

About Exro Technologies Inc.

Exro Technologies is a leading clean-technology company that has developed new-generation power control electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries. The company’s innovative technologies serve to bridge the performance-cost gap in e-mobility (Coil Driver(TM)) and stationary energy storage (Cell Driver(TM))), and act to accelerate adoption toward a circular electrified economy by delivering more with less — minimum energy for maximum results. For more information about the company, please visit www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. The company today announced that the European Patent Office (“EPO”) has granted a patent for AV-101, Vistagen’s oral NMDAR (N-methyl-D-aspartate receptor) glycine site antagonist. “Expanding our patent portfolio for all of our product candidates is an ongoing priority to support our global development and commercialization strategies across our pipeline,” said Shawn Singh, chief executive officer of Vistagen. “AV-101’s potential to inhibit the function of the NMDAR, without fully blocking it like other NMDAR antagonists such as ketamine, anchors our interest in developing it as an innovative therapy for millions of patients affected by CNS disorders involving the NMDAR. This new patent covering our improved and streamlined manufacturing process may result in advantages for getting AV-101 to patients, on our own or potentially with a partner.”

To view the full press release, visit https://ibn.fm/GJ8gl

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster-acting and with fewer side effects and safety concerns than those that are currently available for treatment of anxiety, depression and multiple CNS disorders. Vistagen’s pipeline includes multiple product candidates, including fasedienol and itruvone, belonging to a new class of drugs known as pherines, in addition to an oral NMDAR antagonist. Pherines, which are administered as nasal sprays, are designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can beneficially impact key neural circuits in the brain without systemic uptake or direct activity on CNS neurons. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression and several other CNS disorders. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles (“EV”), today announced that its subsidiary Solectrac has debuted a new version of its pioneering e25 electric tractor featuring hydrostatic transmission, a mid-PTO and independent PTO operation. Called the e25H, the new tractor will be available for order in the second half of 2023 along with the currently available e25G. “Solectrac was built on a simple idea—Americans who make a living working the land deserve better than noisy, polluting tractors powered by combustion engines. The success of the e25 shows that our premise is right,” said Mani Iyer, Solectrac CEO. “Now, we are going to make our industry leading e25 electric tractor even better with key updates, so our customers can enjoy all the optionality and utility of an equivalent hydrostatic transmission diesel tractor with much less noise and zero pollution.”

To view the full press release, visit https://ibn.fm/9u4sy

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: accelerating the commercial adoption of electric vehicles. By bringing together vehicles, charging and financing solutions under one roof, Ideanomics is the one-stop partner needed to simplify the transition to and operation of any EV fleet. For more information about the company, visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, today announced its entry into a definitive agreement with a health care-focused U.S. institutional investor. The agreement is for the purchase and sale of 1,570,680 shares of the company’s common stock (or common stock equivalents in lieu thereof) in a registered direct offering and warrants to purchase up to 1,570,680 shares of common stock at a purchase price per share (and accompanying warrant) of $1.91 in a concurrent private placement. The registered direct offering and private placement (together referred to as the “offering”) are priced at-the-market under Nasdaq rules. Subject to satisfaction of customary conditions, the closing of the offering is expected to occur on or about April 10, 2023. The company expects to secure approximately $3 million in gross proceeds and intends to use the net proceeds from the offering for research and development expenses and general corporate purposes, including the preparation of a marketing authorization application and legal expenses. A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.

To view the full press release, visit https://ibn.fm/MWT3r

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs, which are seeking to address major unmet needs. The company’s primary focus is a novel program to treat inflammatory disorders using anti-TNF (tumor necrosis factor).

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at http://ibn.fm/ATNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

CISO Global Inc. (NASDAQ: CISO), formerly Cerberus Cyber Sentinel Corp., an industry leader in managed cybersecurity and compliance services, recently announced it had achieved SOC 2(R) Type II certification. “Achieving the SOC 2 Type II certification, which was confirmed by an independent audit, is symbolic of CISO’s commitment to providing the highest level of protection and honoring clients’ trust. The certification validates that CISO security controls and data-privacy solutions meet best practices. CISO continues to strengthen its reputation as a managed cybersecurity and compliance provider that can be trusted to secure its customers’ systems. The SOC 2 Type II certification is widely recognized as a symbol of trust and excellence. This certification involves an in-depth review of controls relevant to security, availability, processing integrity, confidentiality and privacy, and provides compliance attestation for service providers worldwide,” a recent article explains. “We believe that the relationship with our clients must be built on trust,” Ashley Devoto, the company’s president and chief information security officer, is quoted as saying. “As companies increase their usage of vendors and partners to perform activities that are core to their business operations and strategies, there is a need for the highest level of confidence and transparency into service providers’ ability to safeguard customer data.”

To view the full article, visit https://ibn.fm/l5aFY

About CISO Global Inc.

CISO is an industry leader as a global cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations, mitigating continuing and emerging security threats and compliance obligations. Interested investors and shareholders are encouraged to follow Cerberus Sentinel on Twitter and LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (OTC: PLTXD) (FSE: WNT1), the digital face of the plant-based community, operating a one-stop shop for plant-based products, today announced that it has added Hungry Planet(R) Inc. to its growing roster of brands adopting its e-commerce fulfillment solutions. The addition of Hungry Planet and its chef-crafted plant-based meats further leverages PlantX’s warehousing and logistics capabilities. “Hungry Planet is a huge win for PlantX, not only because their meats taste great, but because the brand targets the large category of ‘flexitarians,’ those people who aim to eat healthy and conscientiously but still indulge in some meat on occasion,” said PlantX CEO Lorne Rapkin. “We are excited to add Hungry Planet’s authentic and complete range of plant-based meats alongside PlantX’s own diverse product assortment as we serve this incremental audience of consumers.”

To view the full press release, visit https://ibn.fm/q2R6R

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is a one-stop shop for plant-based products. With its fast-growing category verticals, PlantX offers customers across North America more than 5,000 plant-based products. PlantX also has other brands in the PlantX portfolio including a juice brand, a coffee company, a plant shop, and brick-and-mortar grocery stores. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. PlantX’s digital presence works to eliminate the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about the company, visit Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXD are available in the company’s newsroom at https://ibn.fm/PLTXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Friendable (OTC: FDBL), a mobile technology, marketing and software services provider, plans to submit federal and state-level grant applications in the areas of technology, business and commerce. The company made the announcement, noting that the decision to submit the applications is based on the company’s effort to reduce the costs of acquiring capital; FDBL believes this can be accomplished combining grant submissions with traditional fundraising efforts thereby positioning the company to achieve development and growth capital on a less dilutive basis overall, specifically in relationship to its focus on complement U.S. efforts to ban or replace the TikTok app. “Our efforts remain focused as we set our sights on combining grant funding with traditional capital-raising efforts,” said Friendable CEO Robert A. Rositano Jr. in the press release. “It seemed only logical to explore federal and state level technology grants as the U.S. House of Representatives Foreign Committee voted on a bill that would, on the surface, give the U.S. government the ability to impose a full ban on TikTok, under the Emergency Economic Powers Act. Seeing this unfold has led us to believe there is tremendous power in partnering with the U.S. government in any way shape or form, which I believe can start with technology grants that may assist and align with the goals set out by the U.S. Foreign Affairs Committee. I see opportunity on many fronts as we compartmentalize our technology and platforms for the opportunities that are right in our path. Stay tuned for additional white-label market opportunities we’ve identified for our technology as well.”

To view the full press release, visit https://ibn.fm/MA8xI

About Friendable Inc.

Friendable is a mobile technology, marketing and software services provider. The company has developed a base of technologies that have been productized beginning in 2013 and is now leveraging these various technologies to power certain Friendable-owned brands, as well as white-label offerings to companies or entrepreneurs seeking to enter an existing market quickly and cost effectively, leveraging the many years of technology developed and owned by the company. Friendable is also involved in the marketing, development and identification of products, services or brand opportunities the company feels have mass market potential and scalability. Friendable was founded by brothers Robert A. Rositano Jr. and Dean Rositano, who have more than 27 years of experience working together on technology-related ventures. For more information about the company, visit www.Friendable.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases and conditions, has announced enrollment for its phase 1 study of CycloSam(R) in the treatment of bone cancer. The enrollment is for cohort 2, the second grouping of participants, after cohort 1 was completed in February. “We have met all criteria to continue patient enrollment at a higher dose level in the next group of patients,” said QSAM Biosciences CEO Douglas R. Baum. “We are pleased with the safety data and early signs of efficacy, and we are now moving forward with three active clinical trial sites to continue to recruit, screen and enroll participants in this important study evaluating the safety and early efficacy of CycloSam in patients with metastatic bone cancer. With almost $3 million in funding received in our recently completed private placement, and conversion of all of our outstanding convertible notes into common stock, QSAM is in a much stronger position to advance our clinical trials, achieve several important milestones this year, and create a solid foundation for growth and value creation.”

To view the full press release, visit https://ibn.fm/R9hTL

About QSAM Biosciences Inc.

QSAM Biosciences is developing next-generation nuclear medicines for the treatment of cancer and related diseases. QSAM’s initial technology, CycloSam (Samarium-153 DOTMP), is a clinical-stage, bone-targeting radiopharmaceutical developed by IsoTherapeutics Group LLC, pioneers in the nuclear medicine space that also developed the FDA-approved Quadramet(R) (Samarium-153 EDTMP) radiopharmaceutical product. The QSAM team has designed the CycloSam product with the goal of overcoming the limitations of the Quadramet(R) (Samarium-153 EDTMP) product’s FDA-approved indications. QSAM is led by an experienced executive team and board of directors that have completed numerous FDA approvals and multiple successful biotech exits. CycloSam has demonstrated preliminary safety and efficacy in animal studies and a single-patient, FDA-cleared human trial performed in 2020 at the Cleveland Clinic. This nuclear technology uses low specific activity Samarium-153 (resulting in far less undesirable europium impurity) and DOTMP, a chelator that is believed to reduce or eliminate off-target migration and targets sites of high bone turnover, making it, in management’s opinion, an ideal agent to treat primary and secondary bone cancers. Since CycloSam delivers targeted radiation selectively to the skeletal system, it is also believed to be a great potential candidate for future effectiveness in clinical trials in bone marrow ablation as preconditioning for bone marrow transplantation as well as its future clinical trials in procedures to reduce external beam radiation to bone tumors. This multi-patented drug candidate utilizes a radioisotope previously approved by the FDA, combined with a novel targeting chelant, DOTMP, that has demonstrated preliminary increased efficacy and decreased side effects in animal models and veterinary treatment of bone cancer in dogs. Further, CycloSam utilizes a streamlined, just-in-time manufacturing process that is already in place. Given these factors, management believes there is a strong pathway to commercialization for CycloSam. For more information about the company, please visit www.QSAMBio.com

NOTE TO INVESTORS: The latest news and updates relating to QSAM are available in the company’s newsroom at http://ibn.fm/QSAM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing aid space, today announced the launch of its HearingAssist brand FDA-registered OTC rechargeable hearing aids, including its EZHear Neckband Amplifier and other assorted hearing related supplies on Walgreens.com. “InnerScope continues to execute on its successful B2B sales growth strategy with this latest HearingAssist launch on Walgreens.com,” said Matthew Moore, president and CEO of InnerScope Hearing Technologies. “Walgreens customers can now enjoy the premium rich hearing features offered in the HearingAssist OTC rechargeable hearing aids with prices starting at $499 to $799 a pair compared to similar hearing aids with the same features for thousands of dollars more. With hundreds of thousands of satisfied customers, HearingAssist is America’s No. 1 brand of OTC hearing aids. Furthermore, InnerScope, with its HearingAssist and iHEAR brands of OTC hearing aids, continues to dominate the OTC market with more wholesale distribution and market penetration than any other OTC hearing aid competitor.”

To view the full press release, visit https://ibn.fm/wm4ZP

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope, with its B2B business distribution model offering affordable OTC hearing products through major retailers, pharmacy chains and healthcare service companies, breaks through the barriers that prevent access to effective and affordable hearing solutions. In September 2021, InnerScope acquired iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, which provided access to over 40 patents, an R&D facility and a team of engineers. In addition, InnerScope, in November 2021, acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced and affordable hearing products through Walmart and many other major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Chief Medical Officers, Clinical Research Executives, and Patient Advocacy Experts: attend DGE’s 2nd Diversity in Clinical Trials Summit, taking place May 10-11 in Philadelphia, PA. Join this unique in-person learning and networking experience aimed to remove obstacles in health equity and provide actionable strategies to increase diverse representation in clinical trials.

DGE is bringing together industry-leading experts from global clinical development to discuss the most critical challenges barriers, and methods on how to overcome barriers in order to reduce disparities and achieve health equity. The agenda focuses on increasing representation of underrepresented…

Read More>>

To learn more, please visit https://ibn.fm/r0C5y.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Housing industry and government leaders, specialist delegates, and property experts, are all invited to attend the Future of Housing event taking place on April 25, 2023. Hosted by Sustain SoCal at UCI-Beal Applied Innovation, Irvine, this insightful event will bring the housing community together to nurture best practices and explore ideas.

The Future of Housing event is an assorted continuum of housing stakeholders that collaborate and convene through advocacy, dialogue, education, and research, to develop equitable solutions that serve…

Read More>>

To learn more, please visit https://ibn.fm/qDWDn.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, today announced the release of the latest episode of The Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. Rod Turner, CEO and founder of Manhattan Street Capital, the premier growth capital platform for midsize and startup companies, joined the program to examine the funding platform and share some of the current trends guiding the online capital formation space. “The longer we’re doing this as an industry, the more aware CEOs and CFOs will become regarding when to use an online offering, particularly Reg A+, and which companies are best suited to it. Given how terrible the financial market dynamics are at the moment, we often hear about how the IPO window is closed. That doesn’t mean that the SEC will refuse filings from companies that want to make a public offering… the underwriters say no in a market like this – it’s too expensive, risky and difficult to succeed,” Turner said. “That’s led to a gradually developing method of conducting public offerings called direct listings… It’s been on my radar for some years now to help our client companies make offerings via direct listing, because it’s so much less expensive and you don’t get the door closed in your face for multiple years, which can easily happen in a conventional IPO format.”

To view the full press release, visit https://ibn.fm/nUmdS

About Manhattan Street Capital

Manhattan Street Capital is the premier online fundraising platform focused on helping companies complete IPOs and raise capital using direct listings, Regulation A+, Regulation D and Regulation S, as well as through STO or blockchain offerings that use Reg A+ or Reg D to be legitimate securities offerings. The companies that intend to raise capital with one of these regulations can list their offerings directly on Manhattan Street Capital’s website. Manhattan Street Capital supports the IPO and funding process from start to end, assisting companies with project management and coordination to improve cost efficiency and increase the likelihood of success. For more information, visit the company’s website at www.ManhattanStreetCapital.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Splash Beverage Group (NYSE American: SBEV), a portfolio company of leading beverage brands, announced that it will host a conference call at 10:00 a.m. ET on Tuesday, April 11, 2023, to discuss its previously reported 2022 fourth quarter and full year financial results. Interested parties can join the call by dialing 888-506-0062 (U.S. Toll Free) or 973-528-0011 (international) and entering access code: 766684. In addition, a live webcast will be available and accessible from the Investors’ section of Splash Beverage Group’s website. Attendees are asked to connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. For those unable to join the live event, a replay of the webcast will be available as detailed in the announcement.

To view the full press release, visit https://ibn.fm/3LXOj

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and non-alcoholic beverage brands including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drink. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and the Clean Beverage(R) company, today announced that its board of directors approved a 15-for-1 reverse stock split of the company’s authorized and issued and outstanding shares of common stock, which will be effective under Nevada law on April 5, 2023. According to the update, the company’s common stock will continue to trade on the Nasdaq Capital Market under the current trading symbol, WTER, and will be open for trading on a split-adjusted basis on April 5, 2023. As a result of the reverse stock split, the company’s authorized common stock will decrease from 200,000,000 shares, with a par value of US$0.001 per share, to 13,333,333 shares of common stock, with a par value of US$0.001 per share. The number of its issued and outstanding shares of common stock is expected to decrease from approximately 152,080,692 to approximately 10,138,713. The Alkaline Water Company’s authorized preferred stock will not be affected by the reverse stock split. In association with the reverse stock split, the company’s CUSIP number will change to 01643A306 as of April 5, 2023. The company is effectuating the reverse stock split to increase the per share trading price of its common stock in order to satisfy the US$1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market.

To view the full press release, visit https://ibn.fm/HkeCP

About The Alkaline Water Company

The Alkaline Water Company is the Clean Beverage(R) company making a difference in the water you drink and the world we share. Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for Alkaline88. To purchase The Alkaline Water Company’s products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility to accelerate oncologic drug discovery and enable drug development, has appointed Christoph Reinhard, PhD, MBA, to its Scientific Advisory Board. Reinhard will join other board members who are thought leaders in respective fields to provide invaluable insight into the company’s scientific initiatives and growth strategy. A leader in oncology translational research, new technologies in drug development and external innovation, Reinhard is acting chief scientific officer for CELLphenomics GmbH, where he facilitates and oversees the process of determining what types of novel drugs and drug combinations might best help future cancer patients with solid tumors. Prior to CELLphenomics GmbH, Reinhard worked at Eli Lilly where spearheaded the company’s Innovative Medicine Initiative in Oncology and was directly involved in the development and implementation of the Partners and Outsourcing Strategy for Lilly Singapore’s drug development and biomarker efforts. He is also the cofounder and director of the board of the Asian Cancer Research Group. “We are fortunate to have someone on our Scientific Advisory Board with such extensive experience in the biopharmaceutical industry with a deep understanding of oncology and translational science,” said Predictive Oncology CEO Raymond F. Vennare in the press release. “Dr. Reinhard’s personal and professional commitment is both impressive and honorable, and his insights into oncology drug development will prove invaluable as we continue to gain momentum with oncology drug development partners around the world.”

To view the full press release, visit https://ibn.fm/bhSjF

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The Company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. Together with the Company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based drug discovery solutions, further complimented by its wholly owned CLIA lab and GMP facilities. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that digital health veteran, Eitan Shay, is joining the company in the newly created position of chief product officer. Shay previously served in product leadership roles at digital health companies Livongo and Teladoc Health, as well as senior leadership roles at Meta Platforms. “Demand for our solution continues to accelerate among payers and employers, and the ability to enhance and scale our intelligent platform is central to our growth strategy,” said Erez Raphael, chief executive officer of Dario. “I could not be more excited to welcome Eitan to the Dario team, as his unique background offers a combination of experience in high-growth commercial product environments along with a deep understanding of consumer engagement. Continuous innovation focused on engagement will be key to our long-term success, and I believe Eitan is the ideal candidate to take on this important role.”

To view the full press release, visit https://ibn.fm/mQwgM

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company, revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition platform. Its platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. Dario’s user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Flora (NASDAQ: FLGC), a leading cultivator, manufacturer and distributor of global cannabis products and brands, today announced the certification of its Bogotá-based compound formulation laboratory, Flora Lab 4, following the required regulatory inspection by INVIMA (Colombia’s equivalent to the U.S. Food and Drug Administration). According to the update, the inspection certifies the lab as meeting Current Good Manufacturing Practices standards as determined by INVIMA. “We are very pleased to have received CGMP certification and to bring effective medicinal cannabis treatments to patients in Colombia. We applaud the Colombian government’s acknowledgment of the power of this plant by requiring all health insurance providers to cover the cost of medical cannabis. This policy is fundamental to fair access to these medicines for Colombia’s roughly 30 million eligible patients,” said Luis Merchan, chairman and CEO of Flora. “At Flora, we know the future of cannabis relies heavily on the transformation of this unique plant into mainstream medicines, accessible to the populations who need it most. We are proud to be playing a leading role in the progress toward that goal.”

To view the full press release, visit https://ibn.fm/pmhkK

About Flora Growth Corp.

Flora is a global cannabis company dedicated to bringing the benefits of cannabis to people worldwide. Its commitment is to create, master and connect the international cannabis supply chain by setting the standard for world-class cultivation and manufacturing, thoughtful brand development, and rigorous research and development of medical-grade cannabis products that meet the highest standards of quality, safety and efficacy. Flora’s mission is to create a world where the benefits of cannabis are accessible to everyone, and it is working toward that goal by becoming a leading importer and exporter of cannabis to meet demand in every corner of the market. Visit www.FloraGrowth.com or follow @floragrowthcorp on social media for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, and its subsidiary Solectrac is continuing the rapid expansion of its certified sales and dealer network. The company reported that during Q1 2023, Solectrac added eight certified dealerships with 14 locations in Florida, Texas and California; most new dealers order up to six Solectrac tractors per dealer location for display and customer demonstrations. Solectrac offers marketing and sales support to its dealers. That support includes website development, resources for community engagement, and powerful sales and finance programs along with other tools designed to reach potential customers. “Dealerships are where the magic happens,” said Solectrac CEO Mani Iyer in the press release. “It’s where customers often get their first experience with one of our quiet, clean and powerful electric tractors. That is why I view each dealership location as an important member of the Solectrac community, and I am committed to helping them capture the hearts and minds of customers.”

To view the full press release, visit https://ibn.fm/7dVR5

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: to accelerate the commercial adoption of electric vehicles. By bringing together vehicles, charging and financing solutions under one roof, the company is the one-stop partner needed to simplify the transition to and operation of any EV fleet. For more information about the company, please visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs. The company today announced completion of the training of psychotherapists for its planned phase 2a clinical trial investigating the effects of psilocybin-assisted psychotherapy in the treatment of patients aged 21+ suffering from irritable bowel syndrome (“IBS”) at Massachusetts General Hospital (“MGH”). “We are excited to announce completion of Fluence’s training of psychotherapists for our phase 2a clinical trial in IBS-related pain,” said Jim Gilligan, PhD, chief executive officer of Tryp Therapeutics. “Completion of this training marks a significant step forward in the development of our potentially groundbreaking treatment for patients suffering from this debilitating condition. Collaborating with partners like Harvard/MGH and Fluence, a leader in providing psychotherapeutic training for health professionals administering psychedelic compounds to patients, represents an extraordinary opportunity to advance the field of psychedelic medicine and improve the lives of countless patients.”

To view the full press release, visit https://ibn.fm/OrAav

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida, an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, and a planned phase 2a trial for the treatment of irritable bowel syndrome at Mass General Hospital, all of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Where a preliminary clinical benefit has been demonstrated, subsequent studies are expected to utilize TRP-8803 (IV-infused psilocin), which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Cepton, Inc. recently published its 4Q22 and FY22 financial results
• The company revealed that it had generated FY22 revenues of $7.4 million, up by 65% relative to FY21 results. Furthermore, Cepton guided for FY23 revenues of $15-20 million
• Cepton is at the forefront of lidar technology development, a position they’ve further consolidated with the recent launch of their award-winning Vista® X-120 Plus sensors

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and pioneer within high-performance MMT® lidar solutions, recently announced their financial results for the fourth quarter and full year ending December 31, 2022 (https://ibn.fm/6wp95). The company reported full year 2022 revenues of $7.4 million, within the target guidance provided by Cepton earlier in the year and equivalent to a 65 percent increase year over year. Meanwhile, full year GAAP net income was equivalent to $9.4 million or $0.06 per share. During their release, Cepton provided guidance for their 2023 figures, forecasting full year 2023 revenues to come in at between $15 million to $20 million; meanwhile, the company revealed that they expected 2023 operating expenses to be in line with 2022’s results (i.e., $61.4 million).

The past year has been a momentous one for the company, punctuated by a series of operational and financial highlights. Whether it was unveiling their award-winning Vista® X-120 Plus, the slimmest software definable, top-end automotive lidar for real-time adaptive 3D perception; winning a…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

About TechMediaWire

TechMediaWire (“TMW”) is a tech-focused financial news and content distribution company, one of 50+ brands within IBN, providing: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of corporate communications solutions. As a specialized communications platform with an extensive team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public tech companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By putting a spotlight on the latest and greatest in the tech industry, TMW brings its clients unparalleled visibility, recognition and brand awareness. TMW is where investors come to learn about the next big things in tech and the companies that are making them happen.

To receive SMS text alerts from TechMediaWire, text “TECH” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.TechMediaWire.com

Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://TechMediaWire.com/disclaimer

TechMediaWire (TMW)
Los Angeles, CA
www.TechMediaWire.com
212.418.1217 Office
[email protected]

TechMediaWire is part of IBN.

AnPac Bio-Medical Science (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and entering into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, has announced an asset purchase agreement. The agreement is with Easy Hundred Inc., a U.S.-based e-commerce company in the food-service industry. According to the agreement, AnPac is set to acquire fixed assets of Easy Hundred and Easy Hundred’s intellectual property specifically related to ez100 I, a restaurant supply e-commerce platform; 2Supply, an online marketplace for restaurant suppliers and operators; and 100WAY, which focuses on restaurant reviews and discounts and offers offering effective marketing approaches for restaurants to connect with their customers. The announcement noted that assets include a full set of e-commerce platform source codes, websites, apps, and management systems. “Easy Hundred has some significant shareholders, such as the well-known technology company Menusifu, and has received investments from Amino Capital, Himalaya A Fund III LP, and other institutional investors in the past,” said AnPac Bio-Medical Scienceco-CEO Haohan Xu in the press release. “The acquisition of Easy Hundred’s assets is a strategic initiative to accelerate our business growth in the U.S. food market. Easy Hundred’s one-stop restaurant supplies wholesale platform ez100, online marketplace 2Supply, and restaurant reviews and discounts app 100WAY will provide us with a strong foundation for our business development and expansion in the U.S.”

To view the full press release, visit https://ibn.fm/MLrjF

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of June 30, 2022. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. The company is entering the business-to-business e-commerce food business with the formation of its wholly owned subsidiary Fresh2 Technology and the acquisition of Fresh2 Ecommerce Inc. For more information about the company, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

TAAT(R) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) has filed its financial statements for first quarter 2023, the three-month period ended Jan. 31, 2023. Highlights of the report include growth of current assets by 2.9% from the last audited financial statements, totaling $11,000,221; sales increased to $23,286,963 from $469,782 (with costs of goods sold of $22,178,902 and $337,817, respectively); and gross profit of $1,108,061 compared to $131,965 in the same period the previous year. The company also reduced expenses by more than 44%. “By significantly reducing the company’s expenses, we have been able to find more efficient ways to grow our branded products,” said TAAT Global Alternatives CEO Michael Saxon in the press release. “Additionally, in the company’s Fiscal Q1 2023, our Ohio-based subsidiary ADCO Distributors Inc. delivered sales growth year-over-year despite challenging headwinds. We thank our retail and institutional shareholders for their continued support as we move forward in 2023.”

To view the full press release, visit https://ibn.fm/DDaSW

About TAAT Global Alternatives Inc.

TAAT Global Alternatives is a vertically integrated consumer product and distribution company, generating more than C$90 million in overall gross revenue annually. TAAT is strategically expanding its product categories including tobacco and reduced-risk alternatives, hemp, kratom and other emerging CPG segments. TAAT facilities include a processing plant in Nevada as well as a distribution center in Canton, Ohio, leveraging existing retail shelf space and pipelines into national wholesale channels. For more information, please visit www.TAATGlobal.com.  

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• The FEXD management team has extensive international experience in developing global fintech platforms and services
• The company in September 2022 announced a business combination with Rana Financial, which provides transfer of funds services between the U.S. and Latin America
• At that same time, FEXD announced the acquisition of Afinoz, a digital lending platform used by India’s leading banks
• In January 2023 the company announced an extension to close its announced business combinations with Rana and Afinoz through April 2023

Fintech Ecosystem Development (NASDAQ: FEXD) is a special purpose acquisition company (“SPAC”) formed for the purpose of effecting one or more business combinations with an intent to focus on the financial technology sector.

The company’s mission is to create and grow a global financial services ecosystem to address unmet mobile money needs in developing and industrialized countries and markets. FEXD plans to achieve this by acquiring and merging with financial technology pioneers that have the potential to help establish…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to FEXD are available in the company’s newsroom at https://ibn.fm/FEXD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

• It is estimated that as a result of the COVID-19 pandemic, cybercrime, including theft, data hacking, and destruction, grew by 600%, forcing nearly every industry to embrace new cybersecurity solutions
• Cybercrime is projected to cost companies worldwide an estimated $10.5 trillion annually by 2025, up from $3 trillion in 2015. However, the hefty upfront cost associated with protecting businesses from these attacks is leaving most SMBs vulnerable
• SideChannel acknowledges this issue, and through its team of vCISOs and vCPOs, it is lowering the barrier of entry to access fundamental cybersecurity services, ultimately providing a robust yet affordable solution
• By doing so, the company is playing a pivotal role in improving cybersecurity attack readiness while making robust cybersecurity solutions more accessible and affordable, particularly to SMBs

SideChannel (OTCQB: SDCH), a company founded on the belief that all enterprises, big or small, can have top-tier security guidance at a manageable cost, recognizes the current cost-prohibitive issue with cybersecurity solutions, and seeks to address it by offering affordable and robust cybersecurity support. In addition, the company acknowledges cybersecurity as a growing concern, and the inability of small and mid-sized businesses (“SMBs”) to access associated services is an issue that needs to be addressed, lest many be put out of business.

It is estimated that due to the COVID-19 pandemic, cybercrime, including everything from theft to data hacking and destruction, grew by 600% (https://ibn.fm/CK27W). This has forced nearly every industry to embrace new solutions and adapt quickly to the changing…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

Endeavor (NYSE: EDR), the parent company of UFC, was featured in a recent Fox Business article that discussed the company’s deal to acquire World Wrestling Entertainment Inc. (NYSE: WWE) from Vince McMahon and form a new public company. “Endeavor will hold a 51% controlling interest in the new company while WWE shareholders will have a 49% stake. The deal values UFC at $12.1 billion and WWE at $9.3 billion. The announcement comes hours after WWE hosted WrestleMania 39 in Inglewood, California,” the article reads. “This is a rare opportunity to create a global live sports and entertainment pureplay built for where the industry is headed,” Endeavor CEO Ari Emanuel was quoted as saying.

To view the full article, visit https://ibn.fm/X6qPN

About Endeavor Group Holdings Inc.

Endeavor is a global sports and entertainment company, home to many of the world’s most dynamic and engaging storytellers, brands, live events and experiences. The company is comprised of industry leaders including entertainment agency WME; sports, fashion, events and media company IMG; and premier mixed martial arts organization UFC. The Endeavor network specializes in talent representation, sports operations and advisory, event and experiences management, media production and distribution, experiential marketing and brand licensing.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Playgon Games (TSX.V: DEAL) (OTC: PLGNF) (FSE: 7CR), a SaaS technology company delivering innovative mobile live dealer technology to online gaming operators globally, is reporting key milestones for the March 2023 and the first quarter of 2023. According to the announcement, player activity at its live dealer tables has increased significantly, with March being a record-breaking month in wagering, totaling $145 million, a 30% increase over the best month on record. The daily wagering average for the month set another record, totaling $4.6 million and increasing 31% over the previous best daily wagering average for a month. The quarterly wagering turnover increased 21%, from $275 million to $334 million in Q1 2023, with the average daily wagering turnover spiking from $3 million in Q4 2022 to $3.7 million Q1 2023, representing a 23% increase. “These results are again record-breaking numbers for the company led by our best month since we went live,” said Playgon Games CEO Darcy Krogh in the press release. “Not only was the Q1 up by 23% quarter over quarter, but March shattered our best previous month wagering activity by an impressive 30%. Our integration pipeline is strong, we continue to on-board customers, and our business is scaling. This is an exciting time for Playgon; we look forward to announcing entry into new markets and new partnerships very soon.”

To view the full press release, visit https://ibn.fm/IqgPL

About Playgon Games Inc.

Playgon is a SaaS technology company focused on developing and licensing digital content for the growing iGaming market. The company provides a multitenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Playgon’s current software platform includes Live Dealer Casino, E-Table games and Daily Fantasy Sports, which, through a seamless integration at the operator level, allows customer access without having to share or compromise any sensitive customer data. As a true business-to-business digital content provider, Playgon products are ideal turnkey solutions for online casinos, sportsbook operators, land-based operators, media groups and big database companies. For more information about the company, please visit www.Playgon.com. 

NOTE TO INVESTORS: The latest news and updates relating to PLGNF are available in the company’s newsroom at https://ibn.fm/PLGNF  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

NextPlat Corp. (NASDAQ: NXPL), a global e-commerce provider, is reporting on its financial results for the full year ended Dec. 31, 2022. Financial highlights of the report include revenues of $11.7 million, a 51.3% increase over revenue numbers from 2021, with Q4 2022 revenue coming in at $2.6 million, approximately 26.9% higher than the same period in 2021; annual sales at GTC, the company’s European operation, increased 77.9% with sales at OSC, the company’s North American operation, up more than 34.2%. Gross margins totaled 21.2%, a decrease from 24.0% reported for the previous year, and operating expenses for the full year were approximately $9.7 million. Operational and organizational highlights of the year included the company’s completion of its corporate transition to NextPlat Corp., an expanded focus into the high-growth healthcare market through a $7 million investment and recapitalization of Progressive Care Inc., additions to the leadership teams and the continued strengthening of NXPL subsidiaries’ global partner network. “We are pleased to have ended 2022 with continued record top-line performance,” said NextPlat Corp. executive chair and CEO Charles M. Fernandez in the press release. “2022 was also a year of strategic change at NextPlat, one embodied by the change of our corporate name and expansion of our focus beyond our connectivity and communications offerings towards the delivery of technology solutions and services for healthcare through our investment into Progressive Care. Supported by our expanded global e-commerce capabilities and partnerships in the communications and connectivity markets, we intend to participate in the ongoing digital transformation of healthcare, which is reshaping the entire industry, presenting exciting new opportunities for all stakeholders including providers and patients.”

To view the full press release, visit https://ibn.fm/y3q8w

About NextPlat Corp

NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets for physical and digital assets. The company intends to collaborate with businesses, optimizing the ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications services division through its Global Telesat Communications Ltd. and Orbital Satcom Corp. business units, which offer voice, data, tracking and IoT services to customers worldwide through multiple global storefronts. For more information about the company, please visit www.NextPlat.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing aid space, today announced its unaudited financial results for the full year ended Dec. 31, 2022. Among the highlights, InnerScope reported consolidated net revenues of $15,284,327, a net profit of $5,575,892 and a positive EBITA of 36% for the 2022 full year. “This profitable year-end 2022 shows we are on the right path continuing to scale and support our growth, especially now with our success with numerous major retailers requesting to sell our products,” said Matthew Moore, CEO of InnerScope Hearing Technologies. “Our B2B strategy and the retailer relationships we built over the last year created strong momentum that will continue through 2023 and beyond. With only a hand full of competitors in this new emerging OTC hearing aid market, we are confident that we can continue to deliver our high-quality affordable OTC hearing aids to the ever-growing demand from all the retailers.”

To view the full press release, visit https://ibn.fm/L1ZK6

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope, with its B2B business distribution model offering affordable OTC hearing products through major retailers, pharmacy chains and healthcare service companies, breaks through the barriers that prevent access to effective and affordable hearing solutions. In September 2021, InnerScope acquired iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, which provided access to over 40 patents, an R&D facility and a team of engineers. In addition, InnerScope, in November 2021, acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced and affordable hearing products through Walmart and many other major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork